Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
112.93 USD | -1.59% | -5.50% | -10.34% |
11:05am | Ascendis Pharma Gets FDA Orphan Drug Designation for Hypoparathyroidism Treatment | MT |
Sep. 11 | Ascendis Pharma Gets Orphan Drug Exclusivity for Hormone Treatment Yorvipath in U.S. | DJ |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
6.48B | - | |||||
123B | ||||||
123B | - | |||||
32.38B | - | |||||
23.6B | - | |||||
22.43B | - |
- Stock Market
- Equities
- ASND Stock
- Charts Ascendis Pharma A/S
- Sector Chart